Nan-Haw Chow

3.1k total citations · 1 hit paper
69 papers, 2.4k citations indexed

About

Nan-Haw Chow is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Nan-Haw Chow has authored 69 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Molecular Biology, 22 papers in Oncology and 20 papers in Surgery. Recurrent topics in Nan-Haw Chow's work include Genetic factors in colorectal cancer (13 papers), Bladder and Urothelial Cancer Treatments (12 papers) and Liver physiology and pathology (8 papers). Nan-Haw Chow is often cited by papers focused on Genetic factors in colorectal cancer (13 papers), Bladder and Urothelial Cancer Treatments (12 papers) and Liver physiology and pathology (8 papers). Nan-Haw Chow collaborates with scholars based in Taiwan, United States and Russia. Nan-Haw Chow's co-authors include Shu‐Hui Chen, Jue‐Liang Hsu, Sheng‐Yu Huang, Hsiao‐Sheng Liu, Shu-Jem Su, Kee‐Lung Chang, Chung‐Liang Ho, Tzong‐Shin Tzai, Mei‐Lang Kung and Wu‐Chou Su and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Analytical Chemistry.

In The Last Decade

Nan-Haw Chow

69 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Stable-Isotope Dimethyl Labeling for Quantitative Proteomics

2003 568 citations Nan-Haw Chow, Shu‐Hui Chen et al. profile →

Peers

Countries citing papers authored by Nan-Haw Chow

Since Specialization

Citations

This map shows the geographic impact of Nan-Haw Chow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan-Haw Chow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan-Haw Chow more than expected).

Fields of papers citing papers by Nan-Haw Chow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nan-Haw Chow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan-Haw Chow. The network helps show where Nan-Haw Chow may publish in the future.

Co-authorship network of co-authors of Nan-Haw Chow

This figure shows the co-authorship network connecting the top 25 collaborators of Nan-Haw Chow. A scholar is included among the top collaborators of Nan-Haw Chow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nan-Haw Chow. Nan-Haw Chow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The significance of SMARCB1 in the pathogenesis of renal cell carcinoma with rhabdoid features 2021 ·Translational Oncology ·Yi-Wen Wang, Hsiang‐Lin Song, (unknown), (unknown), Hong Chang, (unknown), (unknown), (unknown), (unknown), Nan-Haw Chow, Yuh‐Shyan Tsai	3
2	Urothelial carcinoma with trophoblastic differentiation: Reappraisal of the clinical implication and immunohistochemically features 2021 ·Urologic Oncology Seminars and Original Investigations ·(unknown), (unknown), Hung-Wen Tsai, Chung-Ta Lee, Yi-Wen Wang, (unknown), (unknown), Yuh‐Shyan Tsai, Nan-Haw Chow	6
3	EMP1, EMP 2, and EMP3 as novel therapeutic targets in human cancer 2017 ·Biochimica et Biophysica Acta (BBA) - Reviews on Cancer ·Yi-Wen Wang, (unknown), (unknown), (unknown), Nan-Haw Chow	71
4	RON Nuclear Translocation under Hypoxia Potentiates Chemoresistance to DNA Double-Strand Break–Inducing Anticancer Drugs 2016 ·Molecular Cancer Therapeutics ·Hong Chang, (unknown), (unknown), Chung-Ta Lee, Chia-Jui Yen, Yuh‐Shyan Tsai, Tzong‐Shin Tzai, Shu‐Hui Chen, Nan-Haw Chow	14
5	SH3BGRL3 Protein as a Potential Prognostic Biomarker for Urothelial Carcinoma: A Novel Binding Partner of Epidermal Growth Factor Receptor 2015 ·Clinical Cancer Research ·(unknown), Chin‐Chen Pan, Hong Chang, Ming-Derg Lai, Tzong‐Shin Tzai, Yuh‐Shyan Tsai, Pin Ling, Hsiao‐Sheng Liu, Bi-Fang Lee, (unknown), Chung‐Liang Ho, Shu‐Hui Chen, Nan-Haw Chow	37
6	Antiangiogenesis as the novel mechanism for justicidin A in the anticancer effect on human bladder cancer 2015 ·Anti-Cancer Drugs ·Yi-Wen Wang, (unknown), (unknown), Shen‐Jeu Won, Hung-Wen Tsai, Chung-Ta Lee, Hong-Lin Cheng, Tzong‐Shin Tzai, Hsiao‐Sheng Liu, Nan-Haw Chow	9
7	Hypoxia Promotes Nuclear Translocation and Transcriptional Function in the Oncogenic Tyrosine Kinase RON 2014 ·Cancer Research ·Hong Chang, Hsiao‐Sheng Liu, Ming-Derg Lai, Yuh‐Shyan Tsai, Tzong‐Shin Tzai, (unknown), Nan-Haw Chow	29
8	Verification of Wild-Type EGFR Status in Non–Small Cell Lung Carcinomas Using a Mutant-Enriched PCR on Selected Cases 2014 ·Journal of Molecular Diagnostics ·Yi-Lin Chen, Cheng‐Chan Lu, (unknown), Wen‐Pin Su, (unknown), (unknown), Wenya Huang, Wu‐Chou Su, Nan-Haw Chow, Chung‐Liang Ho	15
9	Lin28B Is an Oncofetal Circulating Cancer Stem Cell-Like Marker Associated with Recurrence of Hepatocellular Carcinoma 2013 ·PLoS ONE ·(unknown), Hung-Wen Tsai, (unknown), (unknown), Yu-Chung Chang, Chia-Jui Yen, (unknown), (unknown), Ting-Tsung Chang, Chung-Ta Lee, An‐Ning Chao, Cheng-Yang Chou, Shih‐Huang Chan, Nan-Haw Chow, (unknown)	48
10	An unusual function of RON receptor tyrosine kinase as a transcriptional regulator in cooperation with EGFR in human cancer cells 2010 ·Carcinogenesis ·Hsiao‐Sheng Liu, Pei-Yin Hsu, Ming-Derg Lai, Hong Chang, Chung‐Liang Ho, Hong-Lin Cheng, (unknown), (unknown), (unknown), Tzong‐Shin Tzai, Nan-Haw Chow	41
11	BIOMED-2 protocols to detect clonal immunoglobulin and T-cell receptor gene rearrangements in B- and T-cell lymphomas in southern Taiwan 2010 ·Leukemia & lymphoma ·Yi-Lin Chen, Ih‐Jen Su, (unknown), Kung‐Chao Chang, Cheng‐Chan Lu, Nan-Haw Chow, Chung‐Liang Ho, Wenya Huang	30
12	Dengue viruses can infect human primary lung epithelia as well as lung carcinoma cells, and can also induce the secretion of IL-6 and RANTES 2007 ·Virus Research ·Ying‐Ray Lee, (unknown), Nan-Haw Chow, Wu‐Wei Lai, Huan-Yao Lei, Chia-Lun Chang, (unknown), Shun‐Hua Chen, Yee-Shin Lin, Trai‐Ming Yeh, Hsiao‐Sheng Liu	42
13	The novel targets for anti-angiogenesis of genistein on human cancer cells 2004 ·Biochemical Pharmacology ·Shu-Jem Su, Trai‐Ming Yeh, Woei‐Jer Chuang, Chung‐Liang Ho, Kee‐Lung Chang, (unknown), Hsiao‐Sheng Liu, Hong-Lin Cheng, Pei-Yin Hsu, Nan-Haw Chow	118
14	The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer 2004 ·Urologic Oncology Seminars and Original Investigations ·Tzong‐Shin Tzai, Yuh‐Shyan Tsai, Nan-Haw Chow	25
15	Identifying the factors and signal pathways necessary for anchorage-independent growth of Ha-ras oncogene-transformed NIH/3T3 cells 2003 ·Life Sciences ·(unknown), (unknown), Chao‐Kai Chou, Nan-Haw Chow, Tzeng‐Horng Leu, Hsiao‐Sheng Liu	5
16	Expression of Oncogene Products HER2/Neu and Ras and Fibrosis-Related Growth Factors bFGF, TGF-β, and PDGF in Bile from Biliary Malignancies and Inflammatory Disorders 2001 ·Digestive Diseases and Sciences ·Wu‐Chou Su, Shu‐Chu Shiesh, Hsiao‐Sheng Liu, Chiung-Yu Chen, Nan-Haw Chow, (unknown)	31
17	Immunohistochemical analysis of epidermal growth factor receptor family members in stage I non-small cell lung cancer 2001 ·The Annals of Thoracic Surgery ·(unknown), Fen-Fen Chen, (unknown), Nan-Haw Chow, Wu‐Chou Su, (unknown), Pei‐Fang Su, (unknown), (unknown), Yau‐Lin Tseng	34
18	Potential value of urinary intercellular adhesion molecule-1 determination in patients with bladder cancer 1998 ·Urology ·Nan-Haw Chow, Chih‐Jen Cheng, (unknown), Hsiao‐Sheng Liu, Tzong‐Shin Tzai, (unknown)	7
19	Modulation of Antitumor Immunity of Tumor-Bearing Mice with Low-Dose Cyclophosphamide 1996 ·Journal of Surgical Research ·Tzong‐Shin Tzai, (unknown), Nan-Haw Chow	11
20	Suprahepatic gallbladder and right lobe anomaly of the liver in patients with biliary cancers 1995 ·Digestive Diseases and Sciences ·Bor‐Shyang Sheu, Xi‐Zhang Lin, Chiung-Yu Chen, Nan-Haw Chow, Pin-Wen Lin, Hong‐Ming Tsai	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact